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Esophageal burn after chloral hydrate ingestion
Chloral hydrate is generally considered to be a safe hypnotic drug, and is commonly used for short-term
sedation before diagnostic procedures. Its irritant actions to the mucous membranes are usually limited. We
report a rare complication of chloral hydrate overdose in an infant. An 8-month-old male infant became
unconscious and required ventilation support after an overdose of chloral hydrate was administered to provide
sedation for an ophthalmologic examination. White plaques and sloughing of the oropharyngeal mucosa
were observed on the next day. Esophagogastroscopy revealed severe corrosive lesions on the whole esophagus.
The child recovered after supportive treatment and his oral intake remained well without dysphagia after 1
year. This report illustrates the potential corrosive effect of chloral hydrate. Strict attention should be paid to
the dosing and administration protocol of chloral hydrate in infants. The condition of the oropharyngeal
mucosa should be carefully monitored after chloral hydrate administration. [J Formos Med Assoc 2006;105(3):
235–237]
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Chloral hydrate is the oldest of the hypnotic de-
pressants and is widely used to sedate children
before diagnostic procedures. Although gen-
erally considered to be safe, adverse effects, such
as central nervous system depression, respirato-
ry depression, and cardiac arrhythmia, are well
known.1 Severe esophageal burn, however, has
rarely been reported as an adverse effect of chlor-
al hydrate ingestion. We report the case of an 8-
month-old male infant who developed severe
esophageal burn following chloral hydrate over-
dose.
Case Report
An 8-month-old male infant fell against the edge
of the bed, causing his right eyelid to become
swollen. He was brought to the ophthalmology
clinic and chloral hydrate (50 mg/kg) was pre-
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scribed to sedate him for ophthalmologic exami-
nation. His body weight was 8.4 kg, but a dose
of 8 g chloral hydrate instead of the correct dose
of 0.4 g was inadvertently given orally. In addition,
the chloral hydrate was insufficiently diluted
with only 15 mL water. Ten minutes after ingest-
ing the chloral hydrate, the patient lost conscious-
ness and was transferred to the emergency room,
where tracheal intubation and assisted mechani-
cal ventilation were instituted. The patient was
hypothermic (body temperature 35.4°C), his heart
rate was 91 bpm, respiratory rate was 20/min,
blood pressure was 57/11 mmHg, and oxygen sat-
uration was 80%.
On physical examination, his extremities were
flaccid, with decreased tendon reflex. Muscle
tone was poor in all of the extremities. Glasgow
Coma Scale score was E1M1VT. Pupils were con-
stricted and unresponsive to light. No focal neuro-
logic deficits were present. Widespread rales were
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diffuse white plaques, ulcerations, and sloughing
of the mucosa in a circumferential pattern over the
whole esophagus, with concomitant hemorrha-
gic gastritis (Figure).
Intravenous corticosteroid (hydrocortisone
40 mg every 6 hours) and H2 blocker were admin-
istered for 3 days. A nasogastric tube was inserted
as an intraluminal stent. Total parenteral nutri-
tion was instituted starting on the 3rd hospital day,
but hypertransaminesemia developed from the
15th hospital day. The infant began feeding via a
nasogastric tube from the 15th hospital day, and
serum aminotransferases gradually returned to
normal. He resumed oral intake with infant for-
mula from the 23rd hospital day, and the nasogas-
tric tube was removed on the 28th hospital day.
The infant was discharged on the 30th hospital
day. Esophagogram was suggested at 1 month
after discharge, but was refused by his parents.
His oral intake remained well without dysphagia
at 1 year after discharge even while eating solid
food. There were no overt neurologic or visual def-
icits at 22 months after discharge.
Discussion
Chloral hydrate is widely used in pediatric patients
undergoing diagnostic procedures. In children,
a single dose of 50–100 mg/kg of body weight
produces adequate sedation. It is generally consi-
dered to be a safe and effective drug in infants and
children.2 Adverse effects, such as central nervous
system depression and cardiac arrhythmia, have
been reported in some children.2
Gastrointestinal irritation is a well-known side
effect of chloral hydrate administration, but it is
usually mild. The irritant actions of chloral hydrate
give rise to an unpleasant taste, epigastric discom-
fort, nausea, and occasional vomiting. Severe irri-
tations to the gastrointestinal tract after chloral
hydrate overdose are rarely reported. A 66-year-
old female orally ingested 18 g of chloral hydrate
in a suicide attempt. Four months later, she devel-
oped esophageal stricture requiring esophageal
dilatation.3 A 25-year-old female developed gas-
heard over both lungs and aspiration of vomited
substance was assumed. Chest radiograph showed
mildly increased infiltration over both hilar areas.
Oropharyngeal mucous membranes and perioral
skin were hyperemic and edematous.
The hemogram showed leukocytosis, with a
white blood cell count of 23,200 cells/mm3. Blood
sugar was 295 mg/dL and venous blood gas analy-
sis showed a pH of 7.27, PaCO2 35.5 mmHg, and
HCO3
– 16.1 mmol/L. Serum alanine aminotrans-
ferase was 21 U/L and creatinine was 0.5 mg/dL.
Results of the electrocardiogram were normal.
Dopamine and dobutamine were continuously
infused. Ampicillin-sulbactam was administered to
treat the aspiration pneumonia.
On the 2nd hospital day, the patient regained
consciousness and inotropic agents were tapered.
Generalized exanthema was found over his en-
tire body. White plaques and sloughing of the
oropharyngeal mucosa were observed. Oropharyn-
geal and esophageal burn were highly suspected.
Esophagogastroscopy was performed and revealed
Figure. Esophagogastroscopy reveals diffuse white plaques, ulcerations, and
sloughing of the mucosa along the whole esophagus: (A) oral cavity;
(B) upper esophagus; (C) middle esophagus; (D) lower esophagus near
the gastroesophageal junction.
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Esophageal burn after chloral hydrate ingestion
tric necrosis 4 days after ingesting 20 g of chloral
hydrate. She was treated with the Roux-en-Y pro-
cedure to bypass the stricture at the esophago-
gastric anastomosis.4 A 68-year-old woman in-
gested 10 g of chloral hydrate in a suicide attempt;
gastric perforation was found immediately after
the chloral hydrate ingestion.5
The pathogenesis of esophageal burn second-
ary to chloral hydrate ingestion is unclear. The
corrosive effects of chloral hydrate may be in-
creased by insufficient dilution and overdose. The
chloral hydrate should be diluted to a concentra-
tion of 10%. In our patient, the 8 g of chloral hy-
drate was diluted with only 15 mL water (53%,
pH 3.45). Because the patient developed gener-
alized exanthema over his entire body, whether
he exhibited an idiosyncratic reaction to chloral
hydrate is another consideration. In our patient,
the esophagogastroscopic examination revealed
severe esophageal burn with diffuse sloughing of
the mucosa along the whole esophagus. General-
ly, the more severe the esophageal burn, the high-
er the likelihood of subsequent stricture formation.
As the efficacy of steroid treatment in preventing
stricture is controversial, and increased vulner-
ability to infection is a concern,6 we used a short-
term course of steroids for controlling any possi-
ble hypersensitivity reaction. Since the natural
course of chloral hydrate-induced esophageal
burn is unknown, it is also difficult to determine
how long the nasogastric tube should be inserted,
and whether or not steroid use is beneficial.
In conclusion, this report illustrates the need
for awareness among pediatricians that chloral
hydrate overdose and inadequate dilution with
water in the sedation of children for diagnostic
procedures can lead to the severe complication of
esophageal and oropharyngeal burn. After chloral
hydrate ingestion, the infant or child should be
assessed for the presence of any oropharyngeal
burn. Early recognition is essential in the manage-
ment of this complication.
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